http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08333390-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3ceb49a54edfbc6b35e9109347c463
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1995-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9dfaf2fdff1364451e86bd432268536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b03d72029121d8f6eba7214e3f15503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e41f9606d3f6a957697dc935d6b9e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c5da1d59c4970302678c382121fcca
publicationDate 1996-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08333390-A
titleOfInvention Peptide and therapeutic agent for autoimmune disease comprising the same
abstract (57) Abstract: A novel peptide, a derivative thereof, and a pharmaceutical composition containing them are provided. The present invention provides the following amino acid sequence: Ala-Lys-Leu-Thr-Phe-Gly-L. The present invention relates to a peptide having ys-Gly-Thr or a derivative thereof, and a pharmaceutical composition containing them, particularly an agent for treating autoimmune diseases. The present invention provides a novel and useful peptide, wherein the peptide of the present invention has an antigen-nonspecific immunosuppressive activity, has less side effects such as antigenicity, and is effective in an antigen-nonspecific manner. Is provided.
priorityDate 1995-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448420970
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03319
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21925356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449159271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424593126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9883259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4428483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453134186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734295
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9UGM3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453739895

Total number of triples: 46.